Global Infection Surveillance Solution Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Solution Type (Software, Services), By Deployment Mode (On-premise, Cloud), By End-User (Clinics, Hospitals, Laboratories), And By Geography - Forecasts From 2022 To 2027

Published:  Sep 2022 Report Code: KSI061613484 Pages: 120

The infection surveillance solution market is estimated to grow at a CAGR of 11.81% to reach a market size of US$962.114 million in 2027 from US$440.317 million in 2020.  

The increasing number of cases of healthcare-associated infections (HAIs) and improving infection control and control solutions are leading to an increase in the adoption of infection surveillance solutions to aid in the proper and effective monitoring of the state of infections in patients and healthcare facilities.

Healthcare-associated infections are one of the most common types of infections that are acquired by patients whilst they are undergoing treatment at hospitals, which have improper sanitation and do not adhere to the disinfection and infection control and prevention policies and the stringent guidelines provided strictly.  According to the statistics provided by the World Health Organization, nosocomial infections, which are generally referred to as healthcare-associated infections, are increasingly frequent and an adverse event that plagues healthcare facilities and healthcare delivery globally. Approximately 7 in the developed countries and 10 in developing countries out of the admitted 100 patients are prone to and will acquire at least one type of healthcare-associated infection. The patients admitted to the neonates, and the intensive care units (ICUs) are also prone to the epidemic burden of healthcare-associated infections that too more in low-income and middle-income countries than the countries with high income.

In addition, the most common infection acquired during the provision of healthcare services is the urinary tract infection (UTI), and the infection that burdens lesser-equipped healthcare settings are surgical site infections (SSIs) and affect about one-third of the operated patients, which is up to nine times more than in the developed countries. In high-income economies, about 30% of patients in ICUs contract at least one healthcare-associated infection; in middle-income and low-income economies, the ICU-associated infections rate is two or three times more, and device-associated infections are 13 times higher than in the US. Even newborns are at high risk in developing countries, with the rate of infections three times or 20 times higher than in high-income countries. This is leading to the market players adopting infection surveillance solutions to effectively maintain the state of the hospital treatments, hospital surroundings, and all the devices and hygiene-related practices that are essential to achieve high infection control and infection prevention to minimize the spread of nosocomial infections. Thus, it plays a key role in augmenting market growth over the forecast period.

The increasing participation of the core organizations in taking steps to tackle the problem of the spread of infection during hospital treatment and encourage different healthcare facilities to make use of infection surveillance solutions.

The Hospital Epidemiology and Infection Control (HEIC), which is a part of John Hopkins Hospital (JHH), has two main objectives, to effectively perform comprehensive surveillance for healthcare-associated infections and to create, implement, support, and sustain interventions based on evidence to prevent HAI’s. This department makes use of the definitions of infection surveillance as provided by the Centers for Disease Control and Prevention (CDC) National Health and Safety Network. The hospital staff from HEIC provides feedback on hand hygiene performance and infection surveillance data to each hospital unit weekly.

The data trends regarding hand hygiene, healthcare-associated infections, and multi-drug-resistant prevention programs are also being reported on a wide range of institutional dashboards as well as quality reports. The primary requirement of an effective and comprehensive must include all the HEIC participation in several unit-based root cause analyses of each of the infections and programs to promote, monitor, and sustain the evidence-based practices.

The segments that need to be paid attention to that require measures are hand hygiene, healthcare-associated infections, and Multi-drug Resistant Organisms (MDROs).

Product Offerings by Major Market Players

The better, advanced, and diverse varieties of infection surveillance solutions and services with enhanced properties can effectively prevent contamination and the spread of diseases to the end-users. These products are being offered by existing and new players in different markets is estimated to lead to increased adoption and propel the market growth further over the forecast period.

Some of the examples of the product offerings are as follows:

  • In May 2019, RLDatix, one of the leading companies that is involved in providing healthcare solutions that provide patients safety solutions, quality improvement, and harm reduction in healthcare, announced that they entered into an acquisition agreement to acquire iContracts, which is one the leading companies dealing in cloud-based solutions for risk management. Through this acquisition, proper and more effective policies can be implemented.
  • Wolters Kluwer, one of the leading companies dealing in the provision of software solutions and services to cater to the demands from clinics and healthcare facilities, improving the product is already provided called the “Sentri 7” for adhering to the strict regulations for infection control and prevention. Artificial Intelligence technology is being added to his product to cater to rising infections caused by the bacteria responsible for this and called the Clostridioides difficile, or C.diff, which is responsible for many deaths and is a  significant concern among healthcare providers and workers. In addition, it can facilitate the rapid treatment of patients and improve treatment outcomes.

The North American region to hold a considerable share over the forecast period and the Asia Pacific to increase its share

The well-positioned healthcare industry, the provision of one the best healthcare facilities in countries such as the US, and the awareness programs being promoted are expected to aid the North American region hold a significant market share over the forecast period. The Asia Pacific region is also estimated to increase its share over the forecast period, which is attributable to the increasing number of investments to accelerate the development of the healthcare industry and provide better healthcare services to the low-income population.

 Recent Developments

  • The latest Philips Capsule Surveillance solution gained 510(k) market clearance from the U.S. Food & Drug Administration (FDA) in March 2022, according to an announcement made by Royal Philips at HIMSS22. This paved the door for extensive deployment across healthcare systems in the USA.
  • IET India began a disease surveillance initiative in April 2022 intending to develop predictive health models utilizing open data. The research should be carried out as a financed CSR project by Siemens Healthineers India in collaboration with CHRI (Centre for Health Research and Innovation).
  • BoxBoat was purchased by IBM Corporation in July 2021. To further IBM's hybrid cloud goal, BoxBoat will expand its portfolio of installation services and container approach.
  • EPISEQ SARS-CoV-2, a cloud-based monitoring software program designed to find variations using samples from positive patients, was introduced by bioMérieux SA in 2021. The platform, which receives an automatic update every week, recognizes variants based on international nomenclatures, along with any new variant of concern as determined by the World Health Organization and the US Centers for Disease Control and Prevention.
  • The Luce Letartre Research Centre at Sainghin-en-Mélantois, in the north of France, was inaugurated in September 2020 by Ecolab Inc. This aided in accelerating its capacity to introduce solutions for the healthcare sector's infection prevention.

COVID-19 Impact on Infection Surveillance Solution Market

The market was positively impacted by COVID-19. There was a severe scarcity of beds, medical personnel, and essential medical supplies in healthcare facilities as a result of the increase in COVID cases. To track and monitor COVID-19 infections in patients and collect information for better patient outcomes, healthcare organizations were forced to implement HCIT solutions, such as infection surveillance solutions, EHRs, telemedicine platforms, and patient registries. Additionally, the pandemic had forced several government agencies and enterprises to implement IT solutions for the healthcare industry.

For instance, the Singaporean government used several strategies to counteract COVID-19. Data collection from the entire nation's population was one of the strategies. In newly established Community Care Facilities (CCFs), the approach called for the deployment of surveillance technologies, with human resources concentrated on managing high-risk patients. In addition to providing general clinical guidelines to the healthcare IT community and healthcare providers, the Office of National Coordinator for Health Information Technology collaborated with the CDC to publish a variety of resources for reporting and tracking COVID-19.

Global Infection Surveillance Solution Market Scope:

Report Metric Details
 Market Size Value in 2020  US$440.317 million
 Market Size Value in 2027  US$962.114 million
 Growth Rate  CAGR of 11.81% from 2020 to 2027
 Base Year  2020
 Forecast Period  2022–2027
 Forecast Unit (Value)  USD Million
 Segments Covered  Solution Type, Deployment Mode, End-User, And Geography
 Regions Covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies Covered RLDatix, Oracle, VigiLanz Corporation, IBM, GOJO Industries, Inc., Wolters Kluwer N.V., Premier, Inc., BD, Baxter, CliniSys (Sunquest)
 Customization Scope  Free report customization with purchase

 

Segmentation:

  • By Solution Type
    • Software
    • Services
  • By Deployment Mode
    • On-premise
    • Cloud
  • By End-User
    • Clinics
    • Hospitals
    • Laboratories
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • UK
      • Germany
      • France
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Indonesia
      • Taiwan
      • Others

Frequently Asked Questions (FAQs)

Q1. What will be the infection surveillance solution market size by 2027?
A1. The infection surveillance solution market is estimated to reach a market size of US$962.114 million by 2027. 


Q2. What is the size of the infection surveillance solution market?
A2. Infection Surveillance Solution Market was valued at US$440.317 million in 2020. 


Q3. What are the growth prospects for the infection surveillance solution market?
A3. The global infection surveillance solution market is estimated to grow at a CAGR of 11.81% during the forecast period. 


Q4. Which region holds the largest market share in the infection surveillance solution market?
A4. The North American region holds a significant share in the infection surveillance solution market owing to the well-positioned healthcare industry, and the provision of one the best healthcare facilities in countries such as the US.


Q5. How is the infection surveillance solution market segmented?
A5. The infection surveillance solution market has been segmented by solution type, deployment mode, end-user, and geography.

1. Introduction
1.1. Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation

2. Research Methodology
2.1. Research Data
2.2. Assumptions

3. Executive Summary
3.1. Research Highlights

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Infection Surveillance Market Analysis, by Solution Type
5.1. Introduction
5.2. Software 
5.3. Services 

6. Infection Surveillance Market Analysis, by Deployment Mode
6.1. Introduction
6.1.1. On-Premise
6.1.2. Cloud

7. Infection Surveillance Market Analysis, by End-User
7.1. Introduction
7.2. Clinics
7.3. Hospitals
7.4. Laboratories

8. Infection Surveillance Market Analysis, by Geography
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. UK
8.4.2. Germany
8.4.3. France
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa 
8.5.1. Saudi Arabia
8.5.2. United Arab Emirates
8.5.3. Israel
8.5.4. Others
8.6. Asia Pacific
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Taiwan
8.6.7. Others

9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix

10. Company Profiles 
10.1. RLDatix
10.2. Oracle
10.3. VigiLanz Corporation
10.4. IBM
10.5. GOJO Industries, Inc.
10.6. Wolters Kluwer N.V.
10.7. Premier, Inc.
10.8. BD
10.9. Baxter
10.10.  CliniSys (Sunquest)

RLDatix

Oracle

VigiLanz Corporation

IBM

GOJO Industries, Inc.

Wolters Kluwer N.V.

Premier, Inc.

BD

Baxter

CliniSys (Sunquest)

Pricing

Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


Confidentiality

We are in compliance with the global privacy laws.

Connect With Us